Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan
Abstract Background We aimed to evaluate the factors associated with baloxavir prescription in Japanese hospitals using a health insurance claim-based database (MDV analyzer), during the 2018/2019 and 2019/2020 influenza seasons. The MDV analyzer contains anonymized claims data from approximately 42...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-02-01
|
| Series: | Journal of Pharmaceutical Health Care and Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40780-023-00274-1 |
| _version_ | 1828041519696707584 |
|---|---|
| author | Naomi Fujiwara Takashi Fujiwara Yuya Ise |
| author_facet | Naomi Fujiwara Takashi Fujiwara Yuya Ise |
| author_sort | Naomi Fujiwara |
| collection | DOAJ |
| description | Abstract Background We aimed to evaluate the factors associated with baloxavir prescription in Japanese hospitals using a health insurance claim-based database (MDV analyzer), during the 2018/2019 and 2019/2020 influenza seasons. The MDV analyzer contains anonymized claims data from approximately 420 Diagnosis Procedure Combination hospitals, and does not contain data from clinics. Methods Data were collected for influenza patients treated with anti-influenza drugs during the 2018/2019 and 2019/2020 influenza seasons. Multivariate analysis was used to identify factors associated with baloxavir prescription. Results During the study period, 322,063 influenza patients were included for analyses. In multivariate analysis, children, female sex, inpatient, hospital bed capacity, and private hospitals were negatively associated with baloxavir prescription. Compared to elderly patients, the adjusted odds ratio (OR) for baloxavir prescription was 0.612 (95% confidence interval (CI), 0.587–0.637) in children aged 6–11 years, and 0.119 (95% CI, 0.111–0.128) in children aged 0–5 years. Compared to small hospitals (bed capacity, 20–299), the adjusted OR for baloxavir prescription was 0.559 (95% CI, 0.540–0.578) in large hospitals (bed capacity, ≥ 500). Conclusion Children, female sex, inpatient, hospital bed capacity, and private hospitals were negatively associated with baloxavir prescription. |
| first_indexed | 2024-04-10T17:17:25Z |
| format | Article |
| id | doaj.art-92d4aa7a4aec4af0b5f04fb4fd2d65c6 |
| institution | Directory Open Access Journal |
| issn | 2055-0294 |
| language | English |
| last_indexed | 2024-04-10T17:17:25Z |
| publishDate | 2023-02-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Pharmaceutical Health Care and Sciences |
| spelling | doaj.art-92d4aa7a4aec4af0b5f04fb4fd2d65c62023-02-05T12:19:24ZengBMCJournal of Pharmaceutical Health Care and Sciences2055-02942023-02-01911510.1186/s40780-023-00274-1Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in JapanNaomi Fujiwara0Takashi Fujiwara1Yuya Ise2Department of Pharmacy, Nippon Medical School HospitalDepartment of Public Health Research, Kurashiki Clinical Research InstituteDepartment of Pharmacy, Nippon Medical School HospitalAbstract Background We aimed to evaluate the factors associated with baloxavir prescription in Japanese hospitals using a health insurance claim-based database (MDV analyzer), during the 2018/2019 and 2019/2020 influenza seasons. The MDV analyzer contains anonymized claims data from approximately 420 Diagnosis Procedure Combination hospitals, and does not contain data from clinics. Methods Data were collected for influenza patients treated with anti-influenza drugs during the 2018/2019 and 2019/2020 influenza seasons. Multivariate analysis was used to identify factors associated with baloxavir prescription. Results During the study period, 322,063 influenza patients were included for analyses. In multivariate analysis, children, female sex, inpatient, hospital bed capacity, and private hospitals were negatively associated with baloxavir prescription. Compared to elderly patients, the adjusted odds ratio (OR) for baloxavir prescription was 0.612 (95% confidence interval (CI), 0.587–0.637) in children aged 6–11 years, and 0.119 (95% CI, 0.111–0.128) in children aged 0–5 years. Compared to small hospitals (bed capacity, 20–299), the adjusted OR for baloxavir prescription was 0.559 (95% CI, 0.540–0.578) in large hospitals (bed capacity, ≥ 500). Conclusion Children, female sex, inpatient, hospital bed capacity, and private hospitals were negatively associated with baloxavir prescription.https://doi.org/10.1186/s40780-023-00274-1BaloxavirInfluenzaAdministrative claims |
| spellingShingle | Naomi Fujiwara Takashi Fujiwara Yuya Ise Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan Journal of Pharmaceutical Health Care and Sciences Baloxavir Influenza Administrative claims |
| title | Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan |
| title_full | Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan |
| title_fullStr | Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan |
| title_full_unstemmed | Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan |
| title_short | Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan |
| title_sort | prescription factors influencing baloxavir prescription during the 2018 2019 and 2019 2020 seasons a administrative database study in japan |
| topic | Baloxavir Influenza Administrative claims |
| url | https://doi.org/10.1186/s40780-023-00274-1 |
| work_keys_str_mv | AT naomifujiwara prescriptionfactorsinfluencingbaloxavirprescriptionduringthe20182019and20192020seasonsaadministrativedatabasestudyinjapan AT takashifujiwara prescriptionfactorsinfluencingbaloxavirprescriptionduringthe20182019and20192020seasonsaadministrativedatabasestudyinjapan AT yuyaise prescriptionfactorsinfluencingbaloxavirprescriptionduringthe20182019and20192020seasonsaadministrativedatabasestudyinjapan |